GSK

GSK Common Stock

£1.34BQuarterly · GBP

Period ending:

GSK FY Common StockGBP
GSK FY Common Stock1986-06-30: £370.00M1987-06-30: £370.00M1988-06-30: £370.00M1989-06-30: £372.00M1990-06-30: £747.00M1991-06-30: £750.00M1992-06-30: £753.00M1993-06-30: £758.00M1994-06-30: £762.00M1995-06-30: £0.001995-12-31: £876.00M1996-12-31: £886.00M1997-12-31: £894.00M1998-12-31: £906.00M1999-12-31: £910.00M2000-12-31: £1.56B2001-12-31: £1.55B2002-12-31: £1.51B2003-12-31: £1.49B2004-12-31: £1.48B2005-12-31: £1.49B2006-12-31: £1.50B2007-12-31: £1.50B2008-12-31: £1.42B2009-12-31: £1.42B2010-12-31: £1.42B2011-12-31: £1.39B2012-12-31: £1.35B2013-12-31: £1.34B2014-12-31: £1.34B2015-12-31: £1.34B2016-12-31: £1.34B2017-12-31: £1.34B2018-12-31: £1.35B2019-12-31: £1.78B2020-12-31: £1.84B2021-12-31: £1.82B2022-12-31: £1.35B2023-12-31: £1.72B2024-12-31: £1.35B2025-12-31: £1.35B£1.84B£0.00
1986-06-302025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in GBP. Dates are period ends; a fiscal year may differ from a calendar year.

GSK common stock history

Par value of issued common shares. The available annual fiscal periods series contains 41 observations from Jun 30, 1986 to Dec 31, 2025.

GSK plc American Depositary Shares (Each representing two Ordinary Shares) Common Stock — Annual fiscal periods (GBP)
Period endingCommon Stock (GBP)
1,346,629,000
1,348,000,000
1,718,430,000
1,347,000,000
1,824,444,000
1,839,915,000
1,783,114,000
1,345,000,000
1,343,000,000
1,342,000,000
1,340,000,000
1,339,000,000
1,336,000,000
1,349,000,000
1,387,000,000
1,418,000,000
1,416,000,000
1,415,000,000
1,503,000,000
1,498,000,000
1,491,000,000
1,484,000,000
1,485,120,000
1,506,000,000
1,546,453,000
1,556,000,000
910,000,000
906,000,000
894,000,000
886,000,000
876,000,000
0
762,000,000
758,000,000
753,000,000
750,000,000
747,000,000
372,000,000
370,000,000
370,000,000
370,000,000

Compare common stock

All GSK financial metrics · GSK stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.